MPR Weekly Dose 108 - OTC Treatment Shows Benefit in COVID-19; Emergency Use Granted to Antibody; Parkinson Disease Tx Available; Veklury Study Results; Safety Concern for Ketamine
This week in COVID related news, a heartburn medication shows benefit in patients; Bebtelovimab is authroized; Veklury is shown to retain antiviral activity against variants. Away from COVID, a functi...
18 Feb 202214min
MPR Weekly Dose 107 - Millions of Molnupiravir Courses Delivered; Guidance on Nonopioid Analgesic Development; Enteral Feeding Tube Warning; Enjaymo Approved; Mecarbil Under Review for HFrEF
This week: news of millions of courses of a COVID-19 oral antiviral being provided to the US government for distribution throughout the country; There's a draft guidance for novel nonopioid analgesics...
11 Feb 202210min
MPR Weekly Dose 106 - FDA Approves COVID-19 Vaccine; EUA Submission for Kids Under 5; COVID Tests Recalled; Vupanorsen Development Ends; Cabenuva Approval Expanded
This week: The approval of a second COVID-19 vaccine; Pfizer and BioNTech submit for Emergency use of their vaccine for children under 5; Pfizer have also stopped development on a potential drug treat...
3 Feb 202213min
MPR Weekly Dose 105 - Antibody Therapies Restricted; Veklury Greenlit for Outpatients; Parsaclisib Indication Withdrawn; Pepaxto Withdrawal Reconsidered; Kimmtrak Approved
Use of monoclonal antibodies restricted due to Omicron; Veklury given the go-ahead as an outpatient treatment; New data produces a reconsideration for Pepaxto withdrawal; And there's a new treatment a...
28 Jan 202211min
MPR Weekly Dose 104 - Two New Atopic Dermatitis Therapies; Counterfeit HIV; Indications Withdrawn for Zydelig; CDC Pediatric Influenza Vaccine Study Results; COVID Test Warning
This week we have news of two new approval for atopic dermatitis; Warnings around counterfeit HIV treatments; Zydelig indications withdrawn; CDC pediatric influenza vaccine study results; And an FDA w...
20 Jan 202212min
MPR Weekly Dose 103 - Novel treatment for insomnia; Magnesium health claim; Dental decay and transmucosal med; Vaccine and menstrual cycle findings; Best diets for 2022
This week: Novel insomnia treatment; The FDA comment on magnesium hypertension claim; Transmucosal buprenorphine linked to dental decay; Researchers assess changes in menstrual cycle in relation to CO...
13 Jan 202212min
MPR Weekly Dose 102 - COVID-19 vaccine contraindication; Final results for COVID-19 antiviral; Entadfi approved; CAR T-cell REMS change; New approval for psoriatic arthritis
Contraindication added to Janssen COVID-19 vaccine; Pfizer announce final results for their COVID-19 oral antiviral; A new treatment for benign prostatic hyperplasia; REMS change for CAR T-cell therap...
17 Des 202114min
MPR Weekly Dose 101 - COVID-19: Pre-exposure prophylaxis approved; Omicron vaccine protection; Antibody authorized for kids; Heterolous boosting assessed; Veklury recall
This week we bring you up to speed on a lot of COVID-related news, despite the emergence of Omicron, there is positive news; Evusheld has become the first pre-exposure prophylaxis for COVID-19; Data s...
10 Des 202113min
